You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bacillus Calmette-Guerin (BCG)

Showing 1 - 25 of 526
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mild Cognitive Impairment, Healthy Trial in Charlestown (Bacillus Calmette-Guerin (BCG))

Active, not recruiting
  • Mild Cognitive Impairment
  • Healthy
  • Bacillus Calmette-Guerin (BCG)
  • Charlestown, Massachusetts
    Clinical Translational Research Unit
Jul 18, 2022

Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

Not yet recruiting
  • Non-Muscle- Invasive Bladder Cancer
  • Durvalumab
  • BCG
  • (no location specified)
Jul 5, 2023

Urinary Bladder Tumors Trial run by the NCI (Durvalumab, Vicineum)

Recruiting
  • Urinary Bladder Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

Recruiting
  • Non Muscle Invasive Bladder Cancer
  • N803 plus Bacillus Calmette-Guerin (BCG)
  • Honolulu, Hawaii
    Island Urology
Aug 7, 2023

Mild Cognitive Impairment, Mild Dementia, Moderate Dementia Trial in Charlestown (Biological/Vaccine: Bacillus Calmette-Guerin

Active, not recruiting
  • Mild Cognitive Impairment
  • +3 more
  • Biological/Vaccine: Bacillus Calmette-Guerin (BCG)
  • Charlestown, Massachusetts
    Alzheimer's Clinical and Translational Research Unit
Feb 2, 2023

Bladder Cancer, High Risk Superficial Trial in United States (Bacillus Calmette-Guérin (BCG))

Completed
  • Bladder Cancer
  • High Risk Superficial
  • Bacillus Calmette-Guérin (BCG)
  • Basking Ridge, New Jersey
  • +4 more
Feb 28, 2022

Recurrent Bladder Carcinoma, Stage 0a Bladder Urothelial Carcinoma, Stage 0is Bladder Urothelial Carcinoma Trial in Chicago (BCG

Active, not recruiting
Has Results
  • Recurrent Bladder Carcinoma
  • +3 more
  • BCG Solution
  • +3 more
  • Chicago, Illinois
    Northwestern University
Sep 27, 2022

Tuberculosis Trial (Intradermal BCG (bacillus calmette-guerin) vaccine AJV)

Not yet recruiting
  • Tuberculosis
  • Intradermal BCG (bacillus calmette-guerin) vaccine AJV
  • (no location specified)
Apr 17, 2023

HIV-1-infection Trial in Zurich (BCG Vaccine AJVaccines)

Recruiting
  • HIV-1-infection
  • BCG Vaccine AJVaccines
  • Zurich, Switzerland
    University Hospital Zurich
Jan 28, 2022

Bladder Cancer Trial (pembrolizumab)

Active, not recruiting
  • Bladder Cancer
  • Pembrolizumab
  • +2 more
  • (no location specified)
Oct 11, 2022

Newborn Vaccine Immunogenicity Trial in Fajara, Goroka (Hepatitis B vaccine (HBV), Bacillus Calmette-Guérin (BCG))

Active, not recruiting
  • Newborn Vaccine Immunogenicity
  • Hepatitis B vaccine (HBV)
  • Bacillus Calmette-Guérin (BCG)
  • Fajara, Gambia
  • +1 more
Jan 12, 2023

Bladder Cancer, Bacillus Calmette-Guerin Trial in Campinas (Bacillus Calmette Guerin, PLACEBO)

Active, not recruiting
  • Bladder Cancer
  • Bacillus Calmette-Guerin
  • Bacillus Calmette Guerin
  • PLACEBO
  • Campinas, SP, Brazil
    Hospital das Clínicas Unicamp
May 18, 2022

Diabetes, Type 1 Diabetes, Diabetes type1 Trial in Charlestown (Bacillus Calmette-Guérin, Saline Injection)

Recruiting
  • Diabetes Mellitus
  • +3 more
  • Bacillus Calmette-Guérin
  • Saline Injection
  • Charlestown, Massachusetts
    Immunobiology Labs CNY 149
May 10, 2023

Bacillus Calmette Guerin With Use of Different Types of Urinary

Completed
  • Non-muscle-invasive Bladder Cancer
  • Marathon, Attica, Greece
    Themistoklis Bellos
Jan 10, 2023

Bladder Cancer Trial in Indianapolis, Baltimore, Rockledge (Dovitinib)

Terminated
Has Results
  • Bladder Cancer
  • Indianapolis, Indiana
  • +2 more
Jul 7, 2022

Fibromyalgia Trial in Charlestown (Bacillus Calmette Guerin Vaccine, Saline Injection)

Withdrawn
  • Fibromyalgia
  • Bacillus Calmette Guerin Vaccine
  • Saline Injection
  • Charlestown, Massachusetts
    Immunobiology Labs CNY 149
Apr 5, 2022

Bladder Cancer, Bladder Cancer Recurrent, Tumor Recurrence Trial (Bacillus Calmette-Guerin: Strain Russian BCG-I, Bacillus

Not yet recruiting
  • Bladder Cancer
  • +5 more
  • Bacillus Calmette-Guerin: Strain Russian BCG-I
  • Bacillus Calmette-Guerin: Strain TICE
  • (no location specified)
Apr 7, 2022

Urothelial Carcinoma, Bladder Cancer Trial in United States (drug, radiation, biological)

Recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • Durvalumab (Cohort 1-3)
  • +7 more
  • Phoenix, Arizona
  • +10 more
Jan 11, 2023

Bladder Cancer Trial in United States (N-803 and BCG, N-803)

Recruiting
  • Bladder Cancer
  • Anchorage, Alaska
  • +31 more
Oct 26, 2022

Non-muscle-invasive Bladder Cancer Trial (Gemcitabine, Docetaxel, Bacillus Calmette Guerin)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • (no location specified)
Sep 9, 2022

Bladder Cancer Trial in Switzerland (Recombinant intravesical BCG (Bacillus Calmette-Guérin VPM1002BC), Atezolizumab, Cisplatin)

Recruiting
  • Bladder Cancer
  • Recombinant intravesical BCG (Bacillus Calmette-Guérin VPM1002BC)
  • +3 more
  • Baden, Switzerland
  • +9 more
Aug 12, 2022

Non Muscle Invasive Bladder Cancer Trial in Korea, Republic of, United States (CG0070, Pembrolizumab Injection,

Recruiting
  • Non Muscle Invasive Bladder Cancer
  • CG0070
  • +2 more
  • Phoenix, Arizona
  • +20 more
Jun 16, 2022

Bladder Urothelial Carcinoma In Situ, Recurrent Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8 Trial in Seattle

Recruiting
  • Bladder Urothelial Carcinoma In Situ
  • +5 more
  • Acupuncture Therapy
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 27, 2022

COVID-19, Therapeutic Vaccine, BCG Trial in Campinas (BCG, Placebo)

Active, not recruiting
  • COVID-19
  • +4 more
  • BCG
  • Placebo
  • Campinas, SP, Brazil
    Hospital das Clínicas Unicamp
Mar 23, 2022

Diabetes, Type 1, Diabetes type1, Autoimmune Diabetes Trial in Charlestown (Bacillus Calmette-Guérin, Saline Injection)

Recruiting
  • Diabetes Mellitus, Type 1
  • +2 more
  • Bacillus Calmette-Guérin
  • Saline Injection
  • Charlestown, Massachusetts
    Immunobiology Labs CNY 149
Mar 22, 2022